KZIA

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Kazia Therapeutics Ltd ADR

NASDAQ | KZIA

9.76

USD

$0.00

(

0.00%

)

At Close (As of Nov 28, 2025)

$16.64M

Market Cap

-

P/E Ratio

-12.22

EPS

$26.30

52 Week High

$2.86

52 Week Low

HEALTHCARE

Sector

KZIA Chart

Recent Chart
Price Action

KZIA Technicals

Tags:

KZIA Earnings

Yearly Income Statement (As of Jun 30, 2025)

Field Value (AUD)
Gross Profit $42K
Total Revenue $42K
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$14M
Selling General And Administrative $8.7M
Research And Development $7.3M
Operating Expenses $14M
Investment Income Net -
Net Interest Income $72K
Interest Income $72K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $934K
Income Before Tax -$22M
Income Tax Expense -$1.7M
Interest And Debt Expense -
Net Income From Continuing Operations -$21M
Comprehensive Income Net Of Tax -
Ebit -$14M
Ebitda -$13M
Net Income -$21M

Revenue & Profitability

Earnings Performance

KZIA Financials

yearly Balance Sheet (As of Jun 30, 2025)

Field Value (AUD)
Total Assets $6.1M
Total Current Assets $4.9M
Cash And Cash Equivalents At Carrying Value $4.3M
Cash And Short Term Investments $4.3M
Inventory -
Current Net Receivables $90K
Total Non Current Assets $1.1M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $1.1M
Intangible Assets Excluding Goodwill $1.1M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $499K
Other Non Current Assets -
Total Liabilities $14M
Total Current Liabilities $14M
Current Accounts Payable $5.6M
Deferred Revenue -
Current Debt -
Short Term Debt $396K
Total Non Current Liabilities $309K
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt $396K
Long Term Debt Noncurrent -
Short Long Term Debt Total $396K
Other Current Liabilities $8M
Other Non Current Liabilities -
Total Shareholder Equity -$8.3M
Treasury Stock -
Retained Earnings -$135M
Common Stock $123M
Common Stock Shares Outstanding $1.1M

yearly Cash Flow (As of Jun 30, 2025)

Field Value (AUD)
Operating Cashflow -$13M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $934K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $16M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$21M

yearly Income Statement (As of Jun 30, 2025)

Field Value (AUD)
Gross Profit $42K
Total Revenue $42K
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$14M
Selling General And Administrative $8.7M
Research And Development $7.3M
Operating Expenses $14M
Investment Income Net -
Net Interest Income $72K
Interest Income $72K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $934K
Income Before Tax -$22M
Income Tax Expense -$1.7M
Interest And Debt Expense -
Net Income From Continuing Operations -$21M
Comprehensive Income Net Of Tax -
Ebit -$14M
Ebitda -$13M
Net Income -$21M

KZIA News

KZIA Profile

Kazia Therapeutics Ltd ADR Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Kazia Therapeutics Ltd ADR is a cutting-edge Australian biotechnology company headquartered in Sydney, specializing in the development of novel cancer therapies. The firm is advancing its proprietary drug candidates, notably GDC-0084, through rigorous clinical trials aimed at addressing critical unmet needs in oncology, particularly for brain cancer and other solid tumors. Kazia's focus on targeting essential pathways in cancer biology underscores its commitment to improving patient outcomes. With a robust pipeline and a dedication to scientific innovation and collaborative research, Kazia is strategically positioned to drive advancements in cancer treatment and enhance the therapeutic landscape.

LPTX
+368.57%
$2.05
NVDA
+1.37%
$180.26
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
INHD
-16.32%
$0.22
ZYXI
+115.62%
$1.59
AMZE
+10.76%
$0.39
VINE
+10.76%
$0.39
ONDS
-2.36%
$8.24
AMBR
+56.32%
$2.47
BITF
+11.91%
$3.10
PLUG
+1.53%
$1.98
NIO
-0.72%
$5.46
IPG
-1.95%
$24.57
ASST
+1.80%
$1.13
CLSK
+13.79%
$13.45
AXDX
-61.36%
$0.03
AAL
+3.49%
$13.93
KTTA
+74.52%
$1.85
INTC
+2.73%
$36.81
BMNR
+9.78%
$31.74
GPUS
+15.78%
$0.33
GOOGL
-1.07%
$319.95
SPRC
-9.01%
$2.22
ADAP
-15.14%
$0.05
YGMZ
-34.15%
$0.12
MARA
-0.53%
$11.11
WULF
+6.45%
$14.84
HOOD
+10.92%
$128.20
RUBI
-8.19%
$0.21
F
+0.15%
$13.19
SNDK
-2.47%
$215.04
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
TLRY
+4.76%
$1.03
BTBT
+2.65%
$2.32
LNW
-3.71%
$86.22
CHR
-4.86%
$0.04
ADD
-25.47%
$0.05
GRAB
+1.52%
$5.32
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
PLTR
+1.35%
$165.77
PFE
-0.03%
$25.71
AAPL
+0.20%
$277.55
HBAN
+0.55%
$16.27
AGNC
+1.53%
$10.56
BTG
+3.23%
$4.47
BAC
+0.97%
$52.99
CCL
-1.12%
$25.43
SNAP
-0.39%
$7.61
TWOH
0.00%
$0.00
ACHR
+1.49%
$7.49
RGTI
-1.95%
$25.57
CRWV
+4.20%
$74.29
WLGS
-5.57%
$0.04
ABEV
0.00%
$2.51
MTSR
-0.35%
$70.50
T
-0.15%
$25.82
AEHL
+8.43%
$3.47
IREN
+2.06%
$48.45
NTNX
-17.74%
$48.34
MSFT
+1.78%
$485.50
ITUB
+3.23%
$7.66
DVLT
-3.61%
$2.13
NOK
+0.33%
$6.08
DEFT
+20.86%
$1.39
AFMD
-34.94%
$0.18
KOS
-1.83%
$1.07
HBI
-0.45%
$6.59
HPQ
-1.39%
$23.98
BURU
+7.72%
$0.22
PLTZ
-2.62%
$7.43
APLD
+5.05%
$24.94
MNDR
+39.47%
$2.65
SMCI
+1.07%
$32.83
BABA
+0.37%
$157.60
VSA
-14.30%
$0.12
NVTS
+3.86%
$8.34
OSCR
+8.54%
$18.16
SOUN
-1.00%
$11.82
HL
+6.60%
$15.97
HPE
+0.79%
$21.53
GRYP
-10.38%
$1.38
NGD
+6.66%
$7.84
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
KSS
+7.49%
$24.10
BTE
-0.31%
$3.16
RR
-3.35%
$3.46
CMND
-3.06%
$0.15
NVO
+3.50%
$48.71
MU
+2.55%
$230.26
ET
+0.98%
$16.43
KDLY
+7.20%
$0.49
NAKA
+7.20%
$0.49
TMC
+7.36%
$5.83
CSCO
-0.32%
$76.07
CRCL
+3.60%
$72.64
PTCT
+4.00%
$86.25
LPTX
+368.57%
$2.05
NVDA
+1.37%
$180.26
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
INHD
-16.32%
$0.22
ZYXI
+115.62%
$1.59
AMZE
+10.76%
$0.39
VINE
+10.76%
$0.39
ONDS
-2.36%
$8.24
AMBR
+56.32%
$2.47
BITF
+11.91%
$3.10
PLUG
+1.53%
$1.98
NIO
-0.72%
$5.46
IPG
-1.95%
$24.57
ASST
+1.80%
$1.13
CLSK
+13.79%
$13.45
AXDX
-61.36%
$0.03
AAL
+3.49%
$13.93
KTTA
+74.52%
$1.85
INTC
+2.73%
$36.81
BMNR
+9.78%
$31.74
GPUS
+15.78%
$0.33
GOOGL
-1.07%
$319.95
SPRC
-9.01%
$2.22
ADAP
-15.14%
$0.05
YGMZ
-34.15%
$0.12
MARA
-0.53%
$11.11
WULF
+6.45%
$14.84
HOOD
+10.92%
$128.20
RUBI
-8.19%
$0.21
F
+0.15%
$13.19
SNDK
-2.47%
$215.04
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
TLRY
+4.76%
$1.03
BTBT
+2.65%
$2.32
LNW
-3.71%
$86.22
CHR
-4.86%
$0.04
ADD
-25.47%
$0.05
GRAB
+1.52%
$5.32
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
PLTR
+1.35%
$165.77
PFE
-0.03%
$25.71
AAPL
+0.20%
$277.55
HBAN
+0.55%
$16.27
AGNC
+1.53%
$10.56
BTG
+3.23%
$4.47
BAC
+0.97%
$52.99
CCL
-1.12%
$25.43
SNAP
-0.39%
$7.61
TWOH
0.00%
$0.00
ACHR
+1.49%
$7.49
RGTI
-1.95%
$25.57
CRWV
+4.20%
$74.29
WLGS
-5.57%
$0.04
ABEV
0.00%
$2.51
MTSR
-0.35%
$70.50
T
-0.15%
$25.82
AEHL
+8.43%
$3.47
IREN
+2.06%
$48.45
NTNX
-17.74%
$48.34
MSFT
+1.78%
$485.50
ITUB
+3.23%
$7.66
DVLT
-3.61%
$2.13
NOK
+0.33%
$6.08
DEFT
+20.86%
$1.39
AFMD
-34.94%
$0.18
KOS
-1.83%
$1.07
HBI
-0.45%
$6.59
HPQ
-1.39%
$23.98
BURU
+7.72%
$0.22
PLTZ
-2.62%
$7.43
APLD
+5.05%
$24.94
MNDR
+39.47%
$2.65
SMCI
+1.07%
$32.83
BABA
+0.37%
$157.60
VSA
-14.30%
$0.12
NVTS
+3.86%
$8.34
OSCR
+8.54%
$18.16
SOUN
-1.00%
$11.82
HL
+6.60%
$15.97
HPE
+0.79%
$21.53
GRYP
-10.38%
$1.38
NGD
+6.66%
$7.84
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
KSS
+7.49%
$24.10
BTE
-0.31%
$3.16
RR
-3.35%
$3.46
CMND
-3.06%
$0.15
NVO
+3.50%
$48.71
MU
+2.55%
$230.26
ET
+0.98%
$16.43
KDLY
+7.20%
$0.49
NAKA
+7.20%
$0.49
TMC
+7.36%
$5.83
CSCO
-0.32%
$76.07
CRCL
+3.60%
$72.64
PTCT
+4.00%
$86.25
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.